Cargando…
New acute treatments for headache
Although we have several acute care medications for the treatment of migraine, we are always looking for new medications to treat our patients. Patients often say that their headaches are not under optimal control and would be happy to try another medication. Patients look for faster onset of relief...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869016/ https://www.ncbi.nlm.nih.gov/pubmed/20464603 http://dx.doi.org/10.1007/s10072-010-0304-7 |
_version_ | 1782181094434537472 |
---|---|
author | Rapoport, Alan M. |
author_facet | Rapoport, Alan M. |
author_sort | Rapoport, Alan M. |
collection | PubMed |
description | Although we have several acute care medications for the treatment of migraine, we are always looking for new medications to treat our patients. Patients often say that their headaches are not under optimal control and would be happy to try another medication. Patients look for faster onset of relief, more complete relief, no recurrent headache and no adverse events. This article will cover some new and some anticipated acute care products, CGRP antagonists, sumatriptan by iontophoretic patch, sumatriptan by needle-free injections, DHE by oral inhalation and diclofenac potassium in a sachet. Botulinum toxin therapy, although a preventive measure, will be mentioned at the end. |
format | Text |
id | pubmed-2869016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-28690162010-05-24 New acute treatments for headache Rapoport, Alan M. Neurol Sci Key Note Lecture Although we have several acute care medications for the treatment of migraine, we are always looking for new medications to treat our patients. Patients often say that their headaches are not under optimal control and would be happy to try another medication. Patients look for faster onset of relief, more complete relief, no recurrent headache and no adverse events. This article will cover some new and some anticipated acute care products, CGRP antagonists, sumatriptan by iontophoretic patch, sumatriptan by needle-free injections, DHE by oral inhalation and diclofenac potassium in a sachet. Botulinum toxin therapy, although a preventive measure, will be mentioned at the end. Springer Milan 2010-05-13 2010 /pmc/articles/PMC2869016/ /pubmed/20464603 http://dx.doi.org/10.1007/s10072-010-0304-7 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Key Note Lecture Rapoport, Alan M. New acute treatments for headache |
title | New acute treatments for headache |
title_full | New acute treatments for headache |
title_fullStr | New acute treatments for headache |
title_full_unstemmed | New acute treatments for headache |
title_short | New acute treatments for headache |
title_sort | new acute treatments for headache |
topic | Key Note Lecture |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869016/ https://www.ncbi.nlm.nih.gov/pubmed/20464603 http://dx.doi.org/10.1007/s10072-010-0304-7 |
work_keys_str_mv | AT rapoportalanm newacutetreatmentsforheadache |